Stephen R Petteway

Title: The Innovative Contributions of Stephen R. Petteway

Introduction

Stephen R. Petteway is a notable inventor based in West Chester, PA (US). He has made significant contributions to the field of immunology, particularly in the development of peptides that target the human immunodeficiency virus (HIV). His work has implications for vaccine development and therapeutic strategies against HIV.

Latest Patents

Stephen R. Petteway holds a patent for a human immunodeficiency virus (HIV) env-coded peptide. This chemically synthesized 15 amino acid peptide, designated peptide 1-69, corresponds to the sequence of amino acids numbers 308 to 322 (RIQRGPGRAFVTIGK) of the HIV-1 IIIB env-coded protein. The peptide was utilized to immunize animals, resulting in the elicitation of antibodies that block HIV proliferation and inhibit HIV-induced cell fusion in cell culture.

Career Highlights

Petteway's career is marked by his association with E.I. du Pont de Nemours and Company, where he has contributed to various research initiatives. His innovative approach to peptide synthesis and immunization has positioned him as a key figure in the fight against HIV.

Collaborations

Stephen R. Petteway has collaborated with notable colleagues, including William Robert Kenealy and Paul J. Durda. These collaborations have enhanced the research efforts in the field of immunology and contributed to the advancement of HIV-related therapies.

Conclusion

Stephen R. Petteway's work exemplifies the impact of innovative research in combating viral infections. His contributions to the development of HIV-targeting peptides are a testament to his dedication to advancing medical science.